Search
for
Sort by
Research 211–240 of 1000+
- From mechanisms to therapies: current advances breakthroughs in alopecia areata immunopathology
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Reversing Gray Hair: Inspiring the Development of New Therapies Through Research on Hair Pigmentation and Repigmentation Progress
- Real‐world experience and long‐term evaluation of tofacitinib in refractory alopecia areata: A prospective, open‐label, single‐center study in Asian Arab population
- Personalized Medicine in the Field of Inflammatory Skin Disorders
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- BH04 Growing interest: a survey of low-dose oral minoxidil prescribing for hair loss
- Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib
- Alopecia Universalis: Never Give Up?
- Dual improvement of alopecia areata and immune thrombocytopenia with baricitinib: a case report
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Pattern hair loss distribution: a novel presentation for alopecia areata
- DataSheet1_Vitiligo: An Autoimmune Skin Disease and its Immunomodulatory Therapeutic Intervention.PDF
- Updates From 2021 Virtual Dermatology Nurses' Association Convention
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Treatment of Crohn's Disease and Concomitant Alopecia Areata With Tofacitinib
- Considerations for the Treatment Strategy of Relapse After Tofacitinib Therapy in Alopecia Areata
- Comparative Efficacy and Safety of Baricitinib Against Traditional Therapies in Severe Alopecia Areata: A Retrospective Cohort Study
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- Alopecia Areata: Current and Emerging Therapies
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- Pathomechanisms of immune-mediated alopecia
- Ruxolitinib found to cause eyelash growth: a case report
- Mechanisms of autophagy and their implications in dermatological disorders
- Case Report: Reversal of Long-Standing Refractory Diffuse Non-Scarring Alopecia Due to Systemic Lupus Erythematosus Following Treatment With Tofacitinib
- II Consensus of the Brazilian Society of Dermatology for the treatment of alopecia areata
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Clinical Case of Tofacitinib Therapy in Autoimmune Alopecia in Patient with Ulcerative Colitis
- Annual Convention in the Time of COVID